SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Ligand Pharmaceuticals Inc. Presents Full Data from Successful Phase II Trial of Captisol-Enabled®, Propylene Glycol-Free Melphalan at the BMT Tandem Meetings